Sector: Materials|Industry: Specialty Chemicals|Market Cap: $10.60B|Employees: 9K
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Net sales for the three months ended June 30, 2025, decreased by 7% to $1.33 billion from $1.43 billion in the prior year period, and by 14% for the six months ended June 30, 2025, to $2.41 billion from $2.79 billion. This was primarily due to a $233.3 million decrease in Q2 2025 attributable to unfavorable lithium carbonate and hydroxide market pricing in the Energy Storage segment.
Gross profit dramatically improved to $196.88 million in Q2 2025 from a loss of $10.58 million in Q2 2024, and to $353.18 million for the six months ended June 30, 2025, from $28.36 million in 2024. This led to a net income attributable to Albemarle Corporation of $22.90 million in Q2 2025, a substantial turnaround from a net loss of $188.20 million in Q2 2024.
Net cash provided by operating activities increased by 16% to $538.18 million for the six months ended June 30, 2025, compared to $465.15 million in the prior year period. This improvement was driven by increased earnings from Specialties and Ketjen segments and a $350 million customer prepayment, partially offset by lower Energy Storage earnings.